Aviva PLC lessened its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 34.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 70,153 shares of the biotechnology company’s stock after selling 36,226 shares during the quarter. Aviva PLC owned 0.09% of Axon Enterprise worth $41,693,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock valued at $5,019,886,000 after purchasing an additional 275,959 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company’s stock valued at $1,095,542,000 after buying an additional 65,097 shares in the last quarter. Alliancebernstein L.P. raised its holdings in shares of Axon Enterprise by 273.8% in the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock valued at $659,128,000 after buying an additional 812,337 shares during the period. Norges Bank acquired a new position in Axon Enterprise during the 4th quarter worth about $482,081,000. Finally, GQG Partners LLC purchased a new position in Axon Enterprise during the 4th quarter valued at about $478,349,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Trading Down 7.9 %
NASDAQ AXON opened at $497.13 on Friday. The firm’s fifty day moving average price is $582.26 and its 200 day moving average price is $554.66. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a market capitalization of $38.09 billion, a price-to-earnings ratio of 128.46, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13.
Insiders Place Their Bets
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on AXON. Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Northcoast Research cut Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Finally, Craig Hallum cut Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $604.67.
Get Our Latest Stock Analysis on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What is the Hang Seng index?
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Airline Stocks – Top Airline Stocks to Buy Now
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What is the S&P/TSX Index?
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.